Standout Papers

Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and A... 2021 2026 2022 2024151
  1. Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations (2021)
    Xiao‐Dong Zhu, Cheng Huang et al. Liver Cancer

Immediate Impact

64 standout
Sub-graph 1 of 24

Citing Papers

Extracellular vesicles in tumor immunity: mechanisms and novel insights
2025 Standout
Hepatocellular carcinoma: signaling pathways and therapeutic advances
2025 Standout
1 intermediate paper

Works of Wen-Kai Shi being referenced

NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma
2020
miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
2018

Author Peers

Author Last Decade Papers Cites
Wen-Kai Shi 205 98 21 181 141 7 417
Sara Torrecilla 243 119 26 200 201 8 493
Tian‐En Li 238 108 32 166 70 9 425
Naofumi Nagasue 169 78 16 140 261 8 486
Concetta Sgarra 230 154 46 113 129 7 417
Kazuma Ohtaka 198 145 9 174 76 8 373
Hidenao Yamamoto 204 116 23 77 207 10 394
Zheng Li 317 67 11 269 85 12 457
Andreas Fischer 230 187 35 76 109 8 396
Floriane Pez 285 91 46 119 55 6 425
Shang-Tian Chuang 232 75 37 102 102 8 447

All Works

Loading papers...

Rankless by CCL
2026